Did John Sutton Get His Eyesight Back Link -

It started with a migraine that felt like a hot needle behind his left eye. Within 48 hours, his vision fractured into a kaleidoscope of static. By day five, he was legally blind. Doctors at the Royal Hallamshire Hospital ran every test imaginable: MRIs, spinal taps, blood panels for rare autoimmune diseases. The diagnosis was chillingly vague— bilateral acute idiopathic optic neuritis . “Your optic nerves are severely inflamed,” the neuro-ophthalmologist told him. “But we can’t find the cause.” No multiple sclerosis. No tumor. No infection. Just… darkness.

He froze. “Margaret,” he whispered. “The sky. I see the sky.” did john sutton get his eyesight back

John Sutton’s story is one of medical mystery, staggering recovery, and the quiet strength of the human spirit. Here is the solidly constructed narrative of whether he got his eyesight back. In the autumn of 2012, John Sutton was a 58-year-old electrician from Sheffield, England—a man who had spent thirty years reading wiring diagrams by flashlight and spotting loose connections in dim ceilings. He had perfect 20/15 vision. Then, in a single, inexplicable week, everything went black. It started with a migraine that felt like

For the next eighteen months, John lived in a world of shadows and echoes. His wife, Margaret, became his eyes. He learned to navigate their terraced house by counting steps. He memorized the angle of the morning sun on his face to tell time. He stopped working. He stopped driving. He stopped hoping. Doctors at the Royal Hallamshire Hospital ran every

He didn’t get back the superhuman vision of his youth. He needs reading glasses now. He has permanent blind spots in his peripheral vision, like small thumbprints on the edges of the world. But he can see his wife’s face. He can see traffic lights. He can see the wiring diagrams he once knew by heart.

In April 2014, a new specialist at St. Thomas’ Hospital in London proposed a radical theory: John might have a rare form of autoinflammatory optic neuropathy triggered by a dormant virus—specifically, varicella-zoster (the chickenpox virus) reactivating in his optic nerves without any rash. The treatment was aggressive: high-dose intravenous steroids for five days, followed by six months of an experimental monoclonal antibody therapy called epratuzumab, which targeted B-cells attacking his nerve sheaths.